Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Früh

Showing results (461-470 of 552) with videos related to

Pageof 56
Sort By:
Science (New York, N.Y.)|December 11, 1999
Impaired immunoproteasome assembly and immune responses in PA28-/- miceT Preckel, W P Fung-Leung, Z Cai, et al.
ESMO Open|November 11, 2025
Sex-specific efficacy and safety outcomes in patients with resectable stage III non-small-cell lung cancer (NSCLC) undergoing neoadjuvant therapies: a pooled analysis of the SAKK trials 16/96, 16/00, 16/01, 16/08 and 16/14L Frehner, S Schär, S Hayoz, et al.
Plos Pathogens|September 1, 2016
Natural Killer Cell Evasion Is Essential for Infection by Rhesus CytomegalovirusElizabeth R Sturgill, Daniel Malouli, Scott G Hansen, et al.
Plos Pathogens|May 17, 2014
T cell inactivation by poxviral B22 family proteins increases viral virulenceDina Alzhanova, Erika Hammarlund, Jason Reed, et al.
ESMO Open|April 10, 2022
Long-term outcomes of operable stage III NSCLC in the pre-immunotherapy era: results from a pooled analysis of the SAKK 16/96, SAKK 16/00, SAKK 16/01, and SAKK 16/08 trialsD König, S Schär, D Vuong, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 30, 2018
Multimodal Treatment in Operable Stage III NSCLC: A Pooled Analysis on Long-Term Results of Three SAKK trials (SAKK 16/96, 16/00, and 16/01)Martin Früh, Daniel C Betticher, Roger Stupp, et al.
Lancet (London, England)|August 16, 2015
Induction chemoradiation in stage IIIA/N2 non-small-cell lung cancer: a phase 3 randomised trialMiklos Pless, Roger Stupp, Hans-Beat Ris, et al.
Scientific Data|July 10, 2026
A Whole-Body PSMA-PET/CT dataset with manually annotated tumor lesionsKatharina Jeblick, Balthasar Schachtner, Andreas Mittermeier, et al.
North American Spine Society Journal|December 24, 2024
Non-cadaveric spine surgery simulator training in neurosurgical residencyPaul Pöser, Robert Schenk, Hannah Miller, et al.
Plos One|March 2, 2021
Alcohol consumption and neurocognitive deficits in people with well-treated HIV in SwitzerlandKatharine E A Darling, Isabella Locatelli, Nadia Benghalem, et al.
Pageof 56

Showing results (461-470 of 552) with videos related to

Sort By:
Pageof 56
Science (New York, N.Y.)|December 11, 1999
Impaired immunoproteasome assembly and immune responses in PA28-/- miceT Preckel, W P Fung-Leung, Z Cai, et al.
ESMO Open|November 11, 2025
Sex-specific efficacy and safety outcomes in patients with resectable stage III non-small-cell lung cancer (NSCLC) undergoing neoadjuvant therapies: a pooled analysis of the SAKK trials 16/96, 16/00, 16/01, 16/08 and 16/14L Frehner, S Schär, S Hayoz, et al.
Plos Pathogens|September 1, 2016
Natural Killer Cell Evasion Is Essential for Infection by Rhesus CytomegalovirusElizabeth R Sturgill, Daniel Malouli, Scott G Hansen, et al.
Plos Pathogens|May 17, 2014
T cell inactivation by poxviral B22 family proteins increases viral virulenceDina Alzhanova, Erika Hammarlund, Jason Reed, et al.
ESMO Open|April 10, 2022
Long-term outcomes of operable stage III NSCLC in the pre-immunotherapy era: results from a pooled analysis of the SAKK 16/96, SAKK 16/00, SAKK 16/01, and SAKK 16/08 trialsD König, S Schär, D Vuong, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 30, 2018
Multimodal Treatment in Operable Stage III NSCLC: A Pooled Analysis on Long-Term Results of Three SAKK trials (SAKK 16/96, 16/00, and 16/01)Martin Früh, Daniel C Betticher, Roger Stupp, et al.
Lancet (London, England)|August 16, 2015
Induction chemoradiation in stage IIIA/N2 non-small-cell lung cancer: a phase 3 randomised trialMiklos Pless, Roger Stupp, Hans-Beat Ris, et al.
Scientific Data|July 10, 2026
A Whole-Body PSMA-PET/CT dataset with manually annotated tumor lesionsKatharina Jeblick, Balthasar Schachtner, Andreas Mittermeier, et al.
North American Spine Society Journal|December 24, 2024
Non-cadaveric spine surgery simulator training in neurosurgical residencyPaul Pöser, Robert Schenk, Hannah Miller, et al.
Plos One|March 2, 2021
Alcohol consumption and neurocognitive deficits in people with well-treated HIV in SwitzerlandKatharine E A Darling, Isabella Locatelli, Nadia Benghalem, et al.
Pageof 56